Rigel Pharmaceuticals (RIGL) Restructuring Costs (2013 - 2016)
Rigel Pharmaceuticals' (RIGL) quarterly Restructuring Costs came in at $5.8 million in Q3 2016, up 239.41% quarter-over-quarter from $1.7 million in Q3 2013.
Rigel Pharmaceuticals (RIGL) Restructuring Costs (2013 - 2016) Analysis & Trends
Rigel Pharmaceuticals' Restructuring Costs history runs 2 years deep, the most recent figure standing at $5.8 million for Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Rigel Pharmaceuticals | 674.25 Mn | 527.57 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 5.77 Mn |
| Sep 30, 2013 | 1.70 Mn |